Syncona Limited Director Declaration
2024年7月4日 - 1:28AM
RNS Regulatory News
RNS Number : 0551V
Syncona Limited
03 July 2024
Syncona
Limited (the "Company")
Director
Declaration
3 July 2024
In accordance with the requirements
of Listing Rule 9.6.14R, the Company advises the following change
to directorships in other publicly quoted companies held by the
following member of the Board:
Dr Kemal Malik was appointed to the
board of directors of Cartesian Therapeutics, Inc (NASDAQ: RNAC) on
1 July 2024.
Enquiries
Syncona Ltd
Alasdair Moodie
Tel: +44 (0) 20 3981 7940
Citco Fund Services (Guernsey)
Limited
Company Secretary
Tel: +44 (0) 1481 758200
About Syncona:
Syncona's purpose is to invest to
extend and enhance human life. We do this by creating, building and
scaling companies to deliver transformational treatments to
patients in areas of high unmet need.
We aim to build and maintain a
diversified portfolio of 20-25 globally leading life science
businesses, across development stage, modality and therapeutic
area, for the benefit of all our stakeholders. We focus on
developing treatments that deliver patient impact by working in
close partnership with world-class academic founders and
experienced management teams. Our balance sheet underpins our
strategy, enabling us to take a long-term view as we look to
improve the lives of patients with no or poor treatment options,
build sustainable life science companies and deliver strong
risk-adjusted returns to shareholders.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
RDNQXLFBZDLLBBQ
Syncona (LSE:SYNC)
過去 株価チャート
から 9 2024 まで 10 2024
Syncona (LSE:SYNC)
過去 株価チャート
から 10 2023 まで 10 2024